Home › Trial NCT01687231
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
- Trial IDNCT01687231
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorDuke University
- Enrollment47
- Start date2009-04
- ConditionsHematologic Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.